An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai
Currently, there is no treatment that slows the progression of the disease, which is the leading cause of vision loss in people over 65.
“This is the first study to show preservation of vision after a single injection of adult-derived human cells into a rat model with age-related macular degeneration,” said Shaomei Wang, MD, PhD, lead author of the study published in the journal STEM CELLS and a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute.
The stem cell injection resulted in 130 days of preserved vision in laboratory rats, which roughly equates to 16 years in humans.
Age-related macular degeneration affects upward of 15 million Americans. It occurs when the small central portion of the retina, known as the macula, deteriorates. The retina is the light-sensing nerve tissue at the back of the eye. Macular degeneration may also be caused by environmental factors, aging and a genetic predisposition.
When animal models with macular degeneration were injected with induced neural progenitor stem cells, which derive from the more commonly known induced pluripotent stem cells, healthy cells began to migrate around the retina and formed a protective layer. This protective layer prevented ongoing degeneration of the vital retinal cells responsible for vision.
Cedars-Sinai researchers in the Induced Pluripotent Stem Cell (iPSC) Core, directed by Dhruv Sareen, PhD, with support from the David and Janet Polak Foundation Stem Cell Core Laboratory, first converted adult human skin cells into powerful induced pluripotent stem cells (iPSC), which can be expanded indefinitely and then made into any cell of the human body. In this study, these induced pluripotent stem cells were then directed toward a neural progenitor cell fate, known as induced neural progenitor stem cells, or iNPCs.
“These induced neural progenitor stem cells are a novel source of adult-derived cells which should have powerful effects on slowing down vision loss associated with macular degeneration,” said Clive Svendsen, PhD, director of the Board of Governors Regenerative Medicine Institute and contributing author to the study. “Though additional pre-clinical data is needed, our institute is close to a time when we can offer adult stem cells as a promising source for personalized therapies for this and other human diseases.”
Read more: Stem Cell Injection May Soon Reverse Vision Loss Caused By Age-Related Macular Degeneration
The Latest on: Age-Related Macular Degeneration
[google_news title=”” keyword=”Age-Related Macular Degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-Related Macular Degeneration
- AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degenerationon April 23, 2024 at 9:50 am
AMD Stopper Inc. is a newly organized company which holds the formulas, patent applications, and intellectual property rights to the formula developed by an eye care researcher to treat Age-Related ...
- Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsighton April 22, 2024 at 2:31 pm
DelveInsight's Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment practices, dry age-related macular degeneration marketed drug, ...
- Age related macular degeneration: What to ask your doctoron April 20, 2024 at 5:00 pm
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your ...
- Rheumatoid arthritis causally linked to increased risk of age-related macular degeneration, suggests studyon April 18, 2024 at 8:30 am
Rheumatoid arthritis causally linked to increased risk of age-related macular degeneration, suggests a study published in the Medicine (Baltimore).This study's goal is to evaluate if there is ...
- Neovascular Age-Related Macular Degenerationon April 17, 2024 at 5:00 pm
Choroidal neovascularization is the primary cause of visual loss in patients with age-related macular degeneration. Current treatments, proven to offer a benefit for these patients through ...
- Wet vs. Dry Macular Degeneration: What Is the Difference?on April 14, 2024 at 5:00 pm
Both types of age-related macular degeneration (AMD) can cause blurriness and visual changes. Dry AMD progresses slowly and causes permanent damage, while wet AMD is more severe but more treatable.
- Global Neovascular Age-Related Macular Degeneration Treatment Market Poised for Significant Growth, Expected to Reach US$ 4.89 Billion by 2033on April 12, 2024 at 1:18 am
According to a new market research report published by Future Market Insights, the global neovascular age-related macular degeneration treatment market is projected to experience a robust growth rate ...
- Age-Related Macular Degeneration and Diabetic Nephropathy: Is there a Connection?on April 9, 2024 at 5:00 pm
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Diabetic nephropathy and age-related macular degeneration (AMD) both lead to serious complications; diabetic ...
- Atrophic macular degeneration: What to knowon March 25, 2024 at 5:00 pm
Atrophic macular degeneration, or geographic atrophy, is an advanced stage of dry age-related macular degeneration. Destruction of the cells — known as atrophy — in the retina can eventually ...
- Neovascular Age-Related Macular Degenerationon March 5, 2024 at 4:00 pm
Randomized, controlled clinical trials have demonstrated the value of laser photocoagulation and photodynamic therapy with verteporfin in selected patients with neovascular age-related macular ...
via Bing News